CANbridge Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 19 Dec 23 | SellHK$4,951,554 | RA Capital Management, L.P. | Company | 58,252,540 | HK$0.085 | |
| 19 Dec 23 | SellHK$332,615 | Farringdon Capital Management | Company | 3,913,050 | HK$0.085 | |
| 15 Dec 23 | BuyHK$4,476,514 | Athos Capital Limited | Company | 52,665,590 | HK$0.085 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Public Companies | 20,554,860 | 4.84% |
| Institutions | 29,876,356 | 7.03% |
| VC/PE Firms | 32,829,330 | 7.73% |
| Individual Insiders | 42,475,430 | 10% |
| Hedge Funds | 49,313,414 | 11.6% |
| General Public | 249,788,930 | 58.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 49,313,414 | HK$15.8m | 0% | 3.34% | |||
| 41,775,430 | HK$13.4m | 0% | no data | |||
| 32,829,330 | HK$10.5m | 0% | 0.14% | |||
| 20,554,860 | HK$6.6m | 0% | no data | |||
| 19,792,100 | HK$6.3m | 0% | 1.46% | |||
| 5,357,576 | HK$1.7m | 0% | 2.34% | |||
| 4,616,680 | HK$1.5m | -38.9% | no data | |||
| 700,000 | HK$224.0k | 0% | no data | |||
| 110,000 | HK$35.2k | 0% | no data |